Spherity Blog

Discover four key takeaways from our DSCSA webinar covering Verification Router Service (VRS), Authorized Trading Partner (ATP) credentials, and interoperability as the November 27 deadline approaches.

Essentra Pharmacy adopts Spherity’s DSCSA ATP credentials early, enhancing patient safety and supply chain security ahead of the 2026 FDA deadline.

The solution for DSCSA Authorized Trading Partner (ATP) verification lies in automation. New technologies, such as the Verification Router Service (VRS) and digital ATP credentials, are changing the game. They enable real-time, automated verification, replacing slow, manual checks with a seamless, interoperable system.

Community pharmacy, Uptown Pharmacy, embraces Spherity’s digital credentials for enhanced efficiency and DSCSA compliance

AvKARE partners with Spherity to deploy ATP Credentials, boosting efficiency, fighting counterfeits, and ensuring DSCSA compliance.

R&S Northeast partners with Spherity to bring digital credentials to the pharmaceutical supply chain, helping ensure that every prescription drug product and trading partner is verified, secure, and DSCSA compliant.

Movilitas.Cloud launches free mobile app to streamline DSCSA verification, enabling fast 2D barcode scanning and instant VRS responses — powered by open digital credentials and backed by Movilitas.Cloud, Spherity, and LedgerDomain.

In May 2025, the Louisiana Board held its second public drug verification exercise—testing VRS, DSCSA Authority & ATP credentials ahead of the May 27 DSCSA exemption deadline. How did it compare to the first? What key insights did participants share?

DSCSA enforcement is finally here after multiple delays, and ATP credentials are essential for compliance, data protection, and cybersecurity. So, how is ATP credential adoption progressing — and where do we stand today?

As the pharma industry moves toward DSCSA compliance, the VRS Provider Network highlights concerns with GLN Allow Lists and how ATP digital credentials address them.

PDG and FDA hosted the first of three DSCSA town halls—explore key points, industry insights, and key takeaways from the session.

Pharma industry updates and key takeaways from the 15th Annual Pharma Serialization & Supply Chain 2025 and HDA DMC 2025.

If you're in digital credentialing, you're part of a global movement, investing in a future-proof, scalable tech. Let's explore examples!

OCI-conformant digital credentials seamlessly interoperable in public Verification Router Service (VRS) exercise.

With the upcoming DSCSA deadline, 6 of the top 10 pharmaceutical companies in the world have partnered with Spherity to enhance data security.

FDA has been keeping its ear to the ground to understand the industry’s DSCSA readiness.

FDA grants large-scale exemption to trading partners on enhanced drug distribution security (EDDS) and related requirements.

The Louisiana Board surveyed DSCSA readiness (Aug–Sep 2024), a timely move ahead of FDA’s Stabilization Period ending Nov 27, 2024.

Read industry updates and key takeaways from the DSCSA Stabilization Period at the HDA Traceability Seminar.

FDA has granted a selective enforcement delay for small dispensers with the definition of ‘small’ being broader than in previous guidance.